AU643427B2
(en)
|
1988-10-31 |
1993-11-18 |
Immunex Corporation |
Interleukin-4 receptors
|
US5714465A
(en)
|
1989-05-19 |
1998-02-03 |
Amgen Inc. |
Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor
|
US7144731B2
(en)
|
1989-10-16 |
2006-12-05 |
Amgen Inc. |
SCF antibody compositions and methods of using the same
|
US5574138A
(en)
|
1993-03-08 |
1996-11-12 |
Immunex Corporation |
Epithelium-derived T-cell factor
|
US7138500B1
(en)
|
1993-05-07 |
2006-11-21 |
Immunex Corporation |
Antibodies to human 4-1BB
|
US7211259B1
(en)
|
1993-05-07 |
2007-05-01 |
Immunex Corporation |
4-1BB polypeptides and DNA encoding 4-1BB polypeptides
|
US7045128B2
(en)
|
1993-05-24 |
2006-05-16 |
Immunex Corporation |
Antibodies against flt3-ligand
|
US6630143B1
(en)
|
1993-05-24 |
2003-10-07 |
Immunex Corporation |
Antibodies against flt3 ligand
|
US6303769B1
(en)
|
1994-07-08 |
2001-10-16 |
Immunex Corporation |
Lerk-5 dna
|
US5885574A
(en)
|
1994-07-26 |
1999-03-23 |
Amgen Inc. |
Antibodies which activate an erythropoietin receptor
|
US5919905A
(en)
|
1994-10-05 |
1999-07-06 |
Immunex Corporation |
Cytokine designated LERK-6
|
US6406901B1
(en)
|
1995-06-08 |
2002-06-18 |
Immunex Corporation |
TNF-a converting enzyme
|
ZA976326B
(en)
|
1996-07-19 |
1998-02-03 |
Amgen Inc |
Analogs of cationic proteins.
|
DK0951551T4
(da)
|
1996-12-23 |
2012-09-10 |
Immunex Corp |
Ligand for NF-kappa B-receptoraktivator, ligand er medlem af TNF-superfamilien
|
US5741772A
(en)
|
1997-02-03 |
1998-04-21 |
Amgen Inc. |
Neurotrophic factor NNT-1
|
US6316408B1
(en)
|
1997-04-16 |
2001-11-13 |
Amgen Inc. |
Methods of use for osetoprotegerin binding protein receptors
|
RO128635A2
(ro)
|
1997-04-16 |
2013-07-30 |
Amgen Inc. |
Anticorp sau fragment al acestuia care se leagă la opgbp şi utilizarea acestuia, utilizarea unei forme solubile de odar, şi metodă de identificare a unui compus care descreşte activitatea opgbp
|
US20020173629A1
(en)
|
1997-05-05 |
2002-11-21 |
Aya Jakobovits |
Human monoclonal antibodies to epidermal growth factor receptor
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
DE69831754T2
(de)
|
1997-12-17 |
2006-06-29 |
Immunex Corp., Thousand Oaks |
Zelloberflächenglycoproteinen zusammenhang mit menschlicher b zell lymphomen - ulbp, dns und polypeptiden
|
CA2316034A1
(fr)
|
1997-12-23 |
1999-07-01 |
Immunex Corporation |
Adn et polypeptides sigirr
|
EP1043335A4
(fr)
|
1997-12-25 |
2005-08-31 |
Japan Tobacco Inc |
Anticorps monoclonal contre le facteur de croissance du tissu conjonctif et ses mises en applications medicales
|
IL137037A0
(en)
|
1998-01-23 |
2001-06-14 |
Immunex Corp |
Acpl dna and polypeptides
|
ES2315016T3
(es)
|
1998-08-07 |
2009-03-16 |
Immunex Corporation |
Moleculas llamadas b7l-1.
|
ATE484587T1
(de)
|
1998-08-07 |
2010-10-15 |
Immunex Corp |
Ldcam genannte moleküle
|
WO2000029581A1
(fr)
|
1998-11-13 |
2000-05-25 |
Immunex Corporation |
Polypeptides de lymphopoietine de stroma thymique humain (tslp), adn et polypeptides associes
|
US6682736B1
(en)
|
1998-12-23 |
2004-01-27 |
Abgenix, Inc. |
Human monoclonal antibodies to CTLA-4
|
US7109003B2
(en)
|
1998-12-23 |
2006-09-19 |
Abgenix, Inc. |
Methods for expressing and recovering human monoclonal antibodies to CTLA-4
|
US7435796B1
(en)
|
1999-02-03 |
2008-10-14 |
Amgen Inc. |
Antibodies which bind B7RP1
|
US7459540B1
(en)
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
JP2001206899A
(ja)
|
1999-11-18 |
2001-07-31 |
Japan Tobacco Inc |
TGF−βII型受容体に対するヒトモノクローナル抗体及びその医薬用途
|
US20030103978A1
(en)
|
2000-02-23 |
2003-06-05 |
Amgen Inc. |
Selective binding agents of osteoprotegerin binding protein
|
AU2001272925A1
(en)
|
2000-05-26 |
2001-12-11 |
Immunex Corporation |
Use of interleukin-4 antagonists and compositions thereof
|
CA2421588C
(fr)
|
2000-09-05 |
2010-01-26 |
Amgen Inc. |
Molecules analogues au recepteur du tnf et ses utilisations
|
NZ569856A
(en)
|
2001-01-05 |
2010-03-26 |
Pfizer |
Antibodies to insulin-like growth factor 1 receptor
|
WO2003024389A2
(fr)
|
2001-07-30 |
2003-03-27 |
Immunex Corporation |
Imx97018, polypeptide humain de type ataxine-1
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
US7658924B2
(en)
|
2001-10-11 |
2010-02-09 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
EP3184539A3
(fr)
|
2001-10-23 |
2017-09-13 |
PSMA Development Company L.L.C. |
Anticorps contre le psma
|
AR039067A1
(es)
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
AU2002351208A1
(en)
|
2001-12-03 |
2003-06-17 |
Abgenix, Inc. |
Antibodies against carbonic anhydrase IX (CA IX) tumor antigen
|
WO2003048327A2
(fr)
|
2001-12-03 |
2003-06-12 |
Abgenix, Inc. |
Anticorps anti-cd45rb s'utilisant dans le traitement de maladies auto-immunes et de rejet de greffon
|
EP1470146B8
(fr)
|
2001-12-28 |
2007-09-12 |
Amgen Fremont Inc. |
Anticorps contre l'antigene muc18
|
ATE394121T1
(de)
|
2001-12-28 |
2008-05-15 |
Amgen Fremont Inc |
Verwendung von antikörpern gegen das muc18- antigen
|
EP1467756A4
(fr)
|
2001-12-28 |
2007-03-21 |
Abgenix Inc |
Procedes d'utilisation d'anticorps anti-muc18
|
US7135174B2
(en)
|
2002-01-07 |
2006-11-14 |
Amgen Fremont, Inc. |
Antibodies directed to PDGFD and uses thereof
|
DK1527100T3
(da)
|
2002-03-29 |
2009-09-07 |
Schering Corp |
Humane monoklonale antistoffer mod interleukin-5 og fremgangsm der og sammens tninger omfattende samme
|
JP4761710B2
(ja)
|
2002-04-05 |
2011-08-31 |
アムジェン インコーポレイテッド |
選択的opgl経路インヒビターとしてのヒト抗opgl中和抗体
|
EP1542724A4
(fr)
|
2002-08-19 |
2005-10-19 |
Abgenix Inc |
Anticorps diriges contre la proteine chimioattractive monocytaire 1 (mcp-1) et leurs utilisations
|
NZ593428A
(en)
|
2002-09-06 |
2013-01-25 |
Amgen Inc |
Therapeutic human anti-il-1r1 monoclonal antibody
|
WO2004034988A2
(fr)
|
2002-10-16 |
2004-04-29 |
Amgen Inc. |
Anticorps humains neutralisants anti-ifn-$g(g) utilises comme inhibiteurs selectifs des voies de ifn-$g(g)
|
US7285269B2
(en)
|
2002-12-02 |
2007-10-23 |
Amgen Fremont, Inc. |
Antibodies directed to tumor necrosis factor
|
DE602004027905D1
(de)
|
2003-05-15 |
2010-08-12 |
Wyeth Llc |
Kontrollierte glukosezufuhr für tierzellkultur
|
MXPA05014152A
(es)
|
2003-06-27 |
2006-05-25 |
Abgenix Inc |
Anticuerpos dirigidos a los mutantes de delecion de receptor de factor de crecimiento epidermico y sus usos.
|
SI1648509T1
(sl)
|
2003-07-15 |
2012-12-31 |
Amgen Inc. |
Humana protitelesa, ki nevtralizirajo anti-ngf, kot selektivni inhibitorji poti nfg
|
US7267960B2
(en)
|
2003-07-25 |
2007-09-11 |
Amgen Inc. |
Antagonists and agonists of LDCAM and methods of use
|
HN2004000285A
(es)
|
2003-08-04 |
2006-04-27 |
Pfizer Prod Inc |
ANTICUERPOS DIRIGIDOS A c-MET
|
ES2321088T3
(es)
|
2003-08-08 |
2009-06-02 |
Amgen Fremont Inc. |
Anticuerpos dirigidos frente a la hormona paratiroidea (pth) y usos de los mismos.
|
US7318925B2
(en)
|
2003-08-08 |
2008-01-15 |
Amgen Fremont, Inc. |
Methods of use for antibodies against parathyroid hormone
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
MXPA06004853A
(es)
|
2003-11-07 |
2006-07-06 |
Immunex Corp |
Anticuerpos que se aglutinan al receptor 4 de interleucina.
|
WO2005058961A2
(fr)
|
2003-12-12 |
2005-06-30 |
Amgen Inc. |
Anticorps anti-galanine et leurs utilisations
|
MX350383B
(es)
|
2004-01-09 |
2017-09-04 |
Pfizer |
Anticuerpos contra madcam.
|
AU2005250341A1
(en)
|
2004-04-23 |
2005-12-15 |
Amgen Inc. |
Antibodies to angiogenesis inhibiting domains of CD148
|
TW200607815A
(en)
|
2004-04-23 |
2006-03-01 |
Amgen Inc |
Anti-CD148 antibodies and binding epitopes therefor
|
JP4840939B2
(ja)
|
2004-08-04 |
2011-12-21 |
アムジェン インコーポレイテッド |
Dkk−1に対する抗体
|
US7423128B2
(en)
|
2004-11-03 |
2008-09-09 |
Amgen Fremont Inc. |
Anti-properdin antibodies, and methods for making and using same
|
DE602005025525D1
(de)
|
2004-11-17 |
2011-02-03 |
Amgen Inc |
Vollständige humane monoklonale antikörper gegen il-13
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
EP1841455A1
(fr)
|
2005-01-24 |
2007-10-10 |
Amgen Inc. |
Anticorps anti-amyloide humanise
|
EP2361933A3
(fr)
|
2005-01-26 |
2012-05-02 |
Amgen Fremont Inc. |
Anticorps contre l'interleukine-1 bêta
|
WO2006104677A2
(fr)
|
2005-03-24 |
2006-10-05 |
Millennium Pharmaceuticals, Inc. |
Anticorps se liant a ov064 et leurs methodes d'utilisation
|
DOP2006000093A
(es)
|
2005-04-25 |
2007-01-31 |
Pfizer |
Anticuerpos contra miostatina
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
HUE028830T2
(en)
|
2005-07-18 |
2017-01-30 |
Amgen Inc |
Human anti-B7RP1 neutralizing antibodies
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
AP2723A
(en)
|
2005-09-07 |
2013-08-31 |
Amgen Fremont Inc |
Human monoclonal antibodies to activ in receptor-like Kinase-1
|
ES2385054T3
(es)
|
2005-12-13 |
2012-07-17 |
Medimmune Limited |
Proteínas de unión específicas para factores de crecimiento de tipo insulina y usos de las mismas
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
US7888482B2
(en)
|
2006-02-10 |
2011-02-15 |
Amgen Inc. |
Antibodies that bind PAR-2
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之c-kit抗體
|
JP2009537143A
(ja)
|
2006-05-19 |
2009-10-29 |
アムゲン インコーポレイティッド |
Sarsコロナウイルスに対する抗体
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
CL2007002668A1
(es)
|
2006-09-20 |
2008-05-09 |
Amgen Inc |
Proteina de union a antigeno que se une al receptor de glucagon humano; acido nucleico que la codifica; metodo de produccion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir la diabetes tipo 2.
|
US7767206B2
(en)
|
2006-10-02 |
2010-08-03 |
Amgen Inc. |
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
|
TW200904470A
(en)
|
2007-04-02 |
2009-02-01 |
Pfizer |
Anti-IgE antibodies
|
CL2008001887A1
(es)
|
2007-06-29 |
2008-10-03 |
Amgen Inc |
Proteinas de union a antigeno que se unen al receptor activado por proteasas 2 (par-2); acido nucleico que las codifica; vector y celula huesped; metodo de produccion; y composicion que las comprende.
|
CL2008002153A1
(es)
|
2007-07-24 |
2009-06-05 |
Amgen Inc |
Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
|
JOP20080381B1
(ar)
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
|
US7982016B2
(en)
|
2007-09-10 |
2011-07-19 |
Amgen Inc. |
Antigen binding proteins capable of binding thymic stromal lymphopoietin
|
EP2261254A3
(fr)
|
2007-12-21 |
2011-04-13 |
Amgen, Inc |
Anticorps anti-amyloïdes et leurs utilisations
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
CA2722600C
(fr)
|
2008-05-01 |
2014-01-21 |
Amgen Inc. |
Anticorps anti-hepcidine et methodes d'utilisation associees
|
SG174344A1
(en)
|
2009-03-20 |
2011-11-28 |
Amgen Inc |
Alpha-4-beta-7 heterodimer specific antagonist antibody
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
WO2013114167A1
(fr)
*
|
2012-01-30 |
2013-08-08 |
Dr. Reddy's Laboratories Limited |
Procédé d'obtention d'une composition de glycoforme
|
WO2013114164A1
(fr)
*
|
2012-01-30 |
2013-08-08 |
Dr. Reddy's Laboratories Limited |
Procédé d'obtention d'une composition glycoprotéique ayant une concentration accrue d'afucosylation
|
EP2765197A1
(fr)
|
2013-02-11 |
2014-08-13 |
ETH Zurich |
Capteur de pH de concepteur en tant que commande transgène universelle
|
EA037565B1
(ru)
*
|
2014-01-29 |
2021-04-14 |
Эмджен Инк. |
Способ снижения содержания высокоманнозных гликоформ рекомбинантного белка
|
WO2015128793A1
(fr)
*
|
2014-02-25 |
2015-09-03 |
Dr. Reddy’S Laboratories Limited |
Procédé pour modifier une composition de glycoprotéine afin d'obtenir une forte teneur en mannose et une galactosylation réduite
|
WO2015128795A1
(fr)
*
|
2014-02-25 |
2015-09-03 |
Dr. Reddy's Laboratories Limited |
Procédé de modification de la galactosylation et de la teneur en g0f d'une composition de glycoprotéine par un apport complémentaire en glutamine
|
WO2015152219A1
(fr)
|
2014-03-31 |
2015-10-08 |
株式会社堀場製作所 |
Electrode, electrode composite et analyseur de liquide
|
DK3227454T3
(da)
*
|
2014-12-01 |
2020-04-14 |
Amgen Inc |
Fremgangsmåde til manipulering af niveauet af glycanindhold på et glycoprotein
|